Home > Pharmacy > Other > Volume-7 > Issue-1 > A Review Immuno-Oncology Agents for Cancer Therapy

A Review Immuno-Oncology Agents for Cancer Therapy

Call for Papers

Volume-8 | Issue-6

Last date : 27-Dec-2024

Best International Journal
Open Access | Peer Reviewed | Best International Journal | Indexing & IF | 24*7 Support | Dedicated Qualified Team | Rapid Publication Process | International Editor, Reviewer Board | Attractive User Interface with Easy Navigation

Journal Type : Open Access

First Update : Within 7 Days after submittion

Submit Paper Online

For Author

Research Area


A Review Immuno-Oncology Agents for Cancer Therapy


Unnati Adhate | Rushikesh Bachhav



Unnati Adhate | Rushikesh Bachhav "A Review Immuno-Oncology Agents for Cancer Therapy" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-7 | Issue-1, February 2023, pp.716-723, URL: https://www.ijtsrd.com/papers/ijtsrd52724.pdf

Until recently, cancer treatment had four main types of treatment: surgery, radiotherapy, chemotherapy and targeted therapies. Over the past decade, immuno-oncology (IO) has emerged as a new and important alternative to cancer treatment by promoting the immune system to kill cancer cells. This newly developed cancer treatment is growing rapidly, with much accelerated approval by the US Food and Drug Administration and the European Medicines Agency in 2019. Cancer immunotherapy (sometimes called immuno-oncology) is to stimulate the immune system to treat cancer, to improve it. in the natural immune system. It is the use of basic research on cancer immunology and the growing subspeciality of oncology. Cancer immunotherapy uses the fact that cancer cells often contain tumor antigens, the molecules on their surface can be detected by antibody proteins of the immune system, which bind to them. Tumor antigens are usually proteins or other macromolecules (e.g., carbohydrates). Normal antibodies bind to foreign viruses, but mutated antibodies bind to tumor antigens that mark and target cancer cells so that the immune system can block or kill. The clinical success of cancer immunotherapy varies greatly between different types of cancer; for example, some subfamilies of stomach cancer respond well to treatment while immunotherapy does not work in other subspecies.

Biomarkers; Cancer; Immune checkpoint inhibitors; Immune-oncology; oncology


IJTSRD52724
Volume-7 | Issue-1, February 2023
716-723
IJTSRD | www.ijtsrd.com | E-ISSN 2456-6470
Copyright © 2019 by author(s) and International Journal of Trend in Scientific Research and Development Journal. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (http://creativecommons.org/licenses/by/4.0)

International Journal of Trend in Scientific Research and Development - IJTSRD having online ISSN 2456-6470. IJTSRD is a leading Open Access, Peer-Reviewed International Journal which provides rapid publication of your research articles and aims to promote the theory and practice along with knowledge sharing between researchers, developers, engineers, students, and practitioners working in and around the world in many areas like Sciences, Technology, Innovation, Engineering, Agriculture, Management and many more and it is recommended by all Universities, review articles and short communications in all subjects. IJTSRD running an International Journal who are proving quality publication of peer reviewed and refereed international journals from diverse fields that emphasizes new research, development and their applications. IJTSRD provides an online access to exchange your research work, technical notes & surveying results among professionals throughout the world in e-journals. IJTSRD is a fastest growing and dynamic professional organization. The aim of this organization is to provide access not only to world class research resources, but through its professionals aim to bring in a significant transformation in the real of open access journals and online publishing.

Thomson Reuters
Google Scholer
Academia.edu

ResearchBib
Scribd.com
archive

PdfSR
issuu
Slideshare

WorldJournalAlerts
Twitter
Linkedin